Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A three-year summary of the Diagnostic and Interventional Radiology Journal | Diagn Interv Radiol | 2026 | 41766377 | PubTator, text mining | PubMed |
| Galanin Receptors: G Protein-Dependent Signaling and Beyond. | Biomolecules | 2026 | 41750307 | PubTator, text mining | PubMed |
| Renal Aspects of the Apelinergic System: Therapeutic Potential and Mechanisms. | Biomolecules | 2026 | 41750255 | PubTator, text mining | PubMed |
| Response to the Letter to the Editor Entitled "SGLT2 Inhibitors in ADPKD: Time to Integrate Cardiovascular Outcomes". | Kidney Int Rep | 2026 | 41727780 | PubTator, text mining | PubMed |
| Use, efficacy, and safety of desmopressin for congenital nephrogenic diabetes insipidus in children: a nationwide survey. | Endocr J | 2026 | 41605691 | PubTator, text mining | PubMed |
| Circulating hormonal and gene expression profile in heat-stressed broilers divergently selected for high or low water efficiency. | Poult Sci | 2026 | 41570528 | PubTator, text mining | PubMed |
| SyMetrics: an integrated machine learning model for evaluating the pathogenicity of synonymous variants in the human genome. | NAR Genom Bioinform | 2026 | 41551927 | PubTator, text mining | PubMed |
| Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry. | Can J Kidney Health Dis | 2026 | 41541406 | PubTator, text mining | PubMed |
| Ion Diffusion and (Photo)redox Conductivity in a Covalent Organic Framework. | J Am Chem Soc | 2026 | 41538321 | PubTator, text mining | PubMed |
| De novo GNAS-Gsα variant (p.Thr55Ala) with constitutive gain-of-function effects on AVPR2 and PTH1R signalings. | J Hum Genet | 2026 | 41530545 | PubTator, text mining | PubMed |
| The biomedical landscape of genomic structural variation in the qatari population. | Nat Commun | 2026 | 41530136 | PubTator, text mining | PubMed |
| Regulation of renal aquaporins: implications in tubular epithelial integrity. | Biochem Soc Trans | 2026 | 41527718 | PubTator, text mining | PubMed |
| Desmopressin Induces Mitochondrial Fragmentation and Dysfunction in Human U87 MG Glioma Cells via CaMKII-Drp1 Signaling Pathway. | Drug Dev Res | 2026 | 41527347 | PubTator, text mining | PubMed |
| Early AI-driven repurposing study of existing drugs towards the vasopressin V2 receptor. | Comput Biol Med | 2026 | 41453266 | PubTator, text mining | PubMed |
| Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease. | Kidney360 | 2026 | 41385299 | PubTator, text mining | PubMed |
| The Need for Novel Therapeutic Directions in Autosomal Dominant Polycystic Kidney Disease Patient Care. | Clin J Am Soc Nephrol | 2026 | 41348481 | PubTator, text mining | PubMed |
| Phenotype and renal outcomes of patients with congenital arginine vasopressin resistance. | Nephrol Dial Transplant | 2026 | 41129383 | PubTator, text mining | PubMed |
| Expression and Function of Vasopressin Receptors in the HT-29 Cell Line. | Curr Mol Med | 2026 | 40635222 | PubTator, text mining | PubMed |
| CANDID Study: Clinical and Molecular Characterization of Congenital Arginine Vasopressin-Resistance and the Use of a Novel Diagnostic Biomarker in Indian Children. | Indian J Pediatr | 2026 | 39992531 | PubTator, text mining | PubMed |
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final report. | Kidney Res Clin Pract | 2026 | 39384353 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=3